The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Compensatory increases in nuclear PGC1α protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats.
Open accessAbstract
OBJECTIVE: We examined in insulin-resistant muscle if, in contrast to long-standing dogma, mitochondrial fatty acid oxidation is increased and whether this is attributed to an increased nuclear content of peroxisome proliferator–activated receptor (PPAR) γ coactivator (PGC) 1α and the adaptations of specific mitochondrial subpopulations. RESEARCH DESIGN AND METHODS: Skeletal muscles from male control and Zucker diabetic fatty (ZDF) rats were used to determine 1) intramuscular lipid distribution, 2) subsarcolemmal and intermyofibrillar mitochondrial morphology, 3) rates of palmitate oxidation in subsarcolemmal and intermyofibrillar mitochondria, and 4) the subcellular localization of PGC1α. Electotransfection of PGC1α cDNA into lean animals tested the notion that increased nuclear PGC1α preferentially targeted subsarcolemmal mitochondria. RESULTS: Transmission electron microscope analysis revealed that in ZDF animals the number (+50%), width (+69%), and density (+57%) of subsarcolemmal mitochondria were increased (P < 0.05). In contrast, intermyofibrillar mitochondria remained largely unchanged. Rates of palmitate oxidation were ∼40% higher (P < 0.05) in ZDF subsarcolemmal and intermyofibrillar mitochondria, potentially as a result of the increased PPAR-targeted proteins, carnitine palmitoyltransferase-I, and fatty acid translocase (FAT)/CD36. PGC1α mRNA and total protein were not altered in ZDF animals; however, a greater (∼70%; P < 0.05) amount of PGC1α was located in nuclei. Overexpression of PGC1α only increased subsarcolemmal mitochondrial oxidation rates. CONCLUSIONS: In ZDF animals, intramuscular lipids accumulate in the intermyofibrillar region (increased size and number), and this is primarily associated with increased oxidative capacity in subsarcolemmal mitochondria (number, size, density, and oxidation rates). These changes may result from an increased nuclear content of PGC1α, as under basal conditions, overexpression of PGC1α appears to target subsarcolemmal mitochondria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![FIG. 5. Whole-muscle, subsarcolemmal (SS), and intermyofibrillar (IMF) mitochondrial enzymatic activities and protein contents in red and white muscle of control and ZDF animals. COXIV (whole muscle [A]; red mitochondria [D]; white mitochondria [G]); CS (whole muscle [B]); CPTI (red mitochondria [E]; white mitochondria [H]); FAT/CD36 (whole muscle [C]; red mitochondria [F]; white mitochondria [I]). Data are expressed as the means ± SE. n = 4–5 for each measure. *Significantly different (P < 0.05) from control animals. †Significantly different (P < 0.05) from red muscle or subsarcolemmal mitochondria.](https://figures.cochat.ai/paper-figures/a64d54191deb46fa93cc869885744da7/compensatory-increases-in-nuclear-pgc1-protein-are-primarily-associated-with-figure-5.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although animal models of insulin resistance appear to have intact mitochondrial capacity (2, 3), humans with insulin resistance seem to have reduced mitochondrial capacity in skeletal muscle.”
The cited source says what the claim attributes to it.
In the citing paper
“Our data suggest that mitochondrial subpopulations are regulated differently in insulin-resistant subjects, an observation that draws a parallel with differential regulation of mitochondrial subpopulations in diabetic (Zucker diabetic fatty) rats (2).”
In the citing paper
“In contrast to humans, rodent models of insulin resistance show intact mitochondrial capacity in skeletal muscle (2, 3), suggesting important interspecies differences.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 2×
“It has been suggested that reductions in PGC1 expression has a role in the etiology of insulin resistance (21,22).”
BackgroundA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864 · cited 1×
“PGC1 , a transcriptional cofactor regulating mitochondrial biogenesis, has been linked to mitochondrial proliferation (19,20) and lipid oxidation (20).”
BackgroundDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990 · cited 1×
“Increased ratios of (14)C -acid soluble intermediates (ASMs) to (14)CO2 have previously been used to infer incomplete oxidation of (14)C-palmitate (41).”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · cited 2×
“It has been suggested that reductions in PGC1 expression has a role in the etiology of insulin resistance (21,22).”
BackgroundHolland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232 · cited 1×
“While the etiology of skeletal muscle insulin resistance remains uncertain, it has been proposed that an accumulation of intramuscular lipids, particularly diacylglycerol (DAG) (1) and ceramides (2,3), may attenuate the insulinsignaling cascade.”
BackgroundHigh-efficiency gene transfer into skeletal muscle mediated by electric pulses
Mir, L. M., Bureau, M. F., Gehl, J., Rangara, R., Rouy, D., Caillaud, J.-M., Delaere, P., Branellec, D., Schwartz, B., & Scherman, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4262 · Cited by 914 · cited 1×
“0 plasmid (500 g pcDNA in 50% vol/vol saline) as described previously (20,38,39).”
MethodDeficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848 · cited 1×
“While the etiology of skeletal muscle insulin resistance remains uncertain, it has been proposed that an accumulation of intramuscular lipids, particularly diacylglycerol (DAG) (1) and ceramides (2,3), may attenuate the insulinsignaling cascade.”
BackgroundMorino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811 · cited 2×
“Others (6,23,24) have also now found that PGC1 is not reduced with insulin resistance in human skeletal muscle.”
Background
Research works printed but not linked: 1
- Srere, 1969, Citrate Synthase. In Methods in Enzymology
Cited by
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
Haemmerle, G., Moustafa, T., Woelkart, G., Büttner, S., Schmidt, A., van de Weijer, T., Hesselink, M., Jaeger, D., Kienesberger, P. C., Zierler, K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2439 · Cited by 761
The role of mitochondria in insulin resistance and type 2 diabetes mellitus
Szendroedi, J., Phielix, E., & Roden, M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.138 · Cited by 600
“In rodent models, insulin resistance can develop in response to high-fat feeding despite a significant compensatory increase in mitochondrial content and enhanced oxidative phosphorylation capacity for fatty acids”
BackgroundPerry, C. G. R., Lally, J., Holloway, G. P., Heigenhauser, G. J. F., Bonen, A., & Spriet, L. L. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.199448 · Cited by 559
“We (Benton et al. 2008a,b, 2010; Holloway et al. 2010; Buddo & Bonen unpublished data) and other groups (Aquilano et al. 2010; Consitt et al. 2010; Xiong et al. 2010) have utilized alternative methods to validate PGC-1α antibodies, namely overexpression or knock down of PGC-1α in mammalian muscle…”
BackgroundMethodInfluentialSelf-citationChomentowski, P., Coen, P. M., Radiková, Z., Goodpaster, B. H., & Toledo, F. G. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0822 · Cited by 163
Benton, C. R., Holloway, G. P., Han, X.-X., Yoshida, Y., Snook, L. A., Lally, J., Glatz, J. F. C., Luiken, J. J. F. P., Chabowski, A., & Bonen, A. (2010) · Diabetologia · doi:10.1007/s00125-010-1773-1 · Cited by 154
“the present and previous studies [3, 24], indicates that PGC-1α targets subsarcolemmal mitochondria.”
MethodResultSelf-citation
Metadata
- Authors
- Holloway, G. P., Gurd, B. J., Snook, L. A., Lally, J., & Bonen, A.
- Affiliations
- University of Guelph (CA)
- Queen's University (CA)
- Corresponding author
- Holloway, Graham P.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-01-26
- Volume
- 59
- Issue
- 4
- Pages
- 819-828
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2844829
- OpenAlex
- W2107275557
- Cited by
- 55
- References
- 49
- Citations by year
- 2025: 1 · 2022: 1 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 5 · 2013: 10 · 2012: 5
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- PGC-1α, subsarcolemmal mitochondria, interfibrillar mitochondria, mitochondrial fatty acid oxidation, palmitate oxidation, skeletal muscle, insulin resistance, Zucker diabetic fatty rats, carnitine palmitoyltransferase 1, FAT/CD36, mitochondrial biogenesis
- MeSH terms
- Acclimatization, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Blood Glucose, Carnitine O-Palmitoyltransferase, DNA, Mitochondrial, Fatty Acids, Nonesterified, Gene Expression Regulation, Insulin, Male, Mitochondria, Muscle, Myofibrils, NADH Dehydrogenase, Rats, Zucker, Reference Values, Sarcolemma, Transcription Factors, Transfection, Triglycerides, RNA-Binding Proteins, DNA Primers, DNA, Complementary, Muscle, Skeletal, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Compensatory increases in nuclear PGC1α protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats. https://app.cochat.ai/papers/10.2337/db09-1519
- The paper
- Holloway, G. P., Gurd, B. J., Snook, L. A., Lally, J., & Bonen, A. (2010). Compensatory increases in nuclear PGC1α protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats. Diabetes. https://doi.org/10.2337/db09-1519
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.